120 related articles for article (PubMed ID: 38049976)
1. 11 C-Acetate PET/CT for Reactive Astrogliosis Outperforms 11 C-Methionine PET/CT in Glioma Classification and Survival Prediction.
Kim D; Yi JH; Park Y; Kim SJ; Kang SG; Kim SH; Chun JH; Chang JH; Yun M
Clin Nucl Med; 2024 Feb; 49(2):109-115. PubMed ID: 38049976
[TBL] [Abstract][Full Text] [Related]
2. Re-evaluation of the diagnostic performance of
Kim D; Chun JH; Kim SH; Moon JH; Kang SG; Chang JH; Yun M
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1678-1684. PubMed ID: 31102001
[TBL] [Abstract][Full Text] [Related]
3. 11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma Classification.
Kim D; Chun JH; Yi JH; Ko HY; Chung JI; Lee M; Park YM; Nam MH; Kim J; Kim SY; Park Y; Moon JH; Kang SG; Chang JH; Lee CJ; Kim SH; Yun M
Clin Nucl Med; 2022 Oct; 47(10):863-868. PubMed ID: 35868002
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Overall Survival Based on Isocitrate Dehydrogenase 1 Mutation and 18F-FDG Uptake on PET/CT in Patients With Cerebral Gliomas.
Kim D; Kim S; Kim SH; Chang JH; Yun M
Clin Nucl Med; 2018 May; 43(5):311-316. PubMed ID: 29485450
[TBL] [Abstract][Full Text] [Related]
5. Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.
Ninatti G; Sollini M; Bono B; Gozzi N; Fedorov D; Antunovic L; Gelardi F; Navarria P; Politi LS; Pessina F; Chiti A
Neuro Oncol; 2022 Sep; 24(9):1546-1556. PubMed ID: 35171292
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of PET/CT with
Ogawa T; Kawai N; Miyake K; Shinomiya A; Yamamoto Y; Nishiyama Y; Tamiya T
EJNMMI Res; 2020 May; 10(1):44. PubMed ID: 32382870
[TBL] [Abstract][Full Text] [Related]
7. The roles of
Kim S; Kim D; Kim SH; Park MA; Chang JH; Yun M
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1012-1020. PubMed ID: 29511838
[TBL] [Abstract][Full Text] [Related]
8. Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.
Poetsch N; Woehrer A; Gesperger J; Furtner J; Haug AR; Wilhelm D; Widhalm G; Karanikas G; Weber M; Rausch I; Mitterhauser M; Wadsak W; Hacker M; Preusser M; Traub-Weidinger T
Neuro Oncol; 2018 Feb; 20(3):411-419. PubMed ID: 29016947
[TBL] [Abstract][Full Text] [Related]
9. [PET/CT with 11C-methionine in assessment of brain glioma metabolism].
Vikhrova NB; Kalaeva DB; Tyurina AN; Belyaev AY; Danilov GV; Pronin IN
Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(1):63-69. PubMed ID: 38334732
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of [
Nakajo K; Uda T; Kawashima T; Terakawa Y; Ishibashi K; Tsuyuguchi N; Tanoue Y; Nagahama A; Uda H; Koh S; Sasaki T; Ohata K; Kanemura Y; Goto T
World Neurosurg; 2021 Apr; 148():e471-e481. PubMed ID: 33444827
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas.
Suzuki K; Kawai N; Ogawa T; Miyake K; Shinomiya A; Yamamoto Y; Nishiyama Y; Tamiya T
EJNMMI Res; 2021 Jul; 11(1):67. PubMed ID: 34291337
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.
Lopci E; Riva M; Olivari L; Raneri F; Soffietti R; Piccardo A; Bizzi A; Navarria P; Ascolese AM; Rudà R; Fernandes B; Pessina F; Grimaldi M; Simonelli M; Rossi M; Alfieri T; Zucali PA; Scorsetti M; Bello L; Chiti A
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1155-1164. PubMed ID: 28110346
[TBL] [Abstract][Full Text] [Related]
13. Estimation of the occurrence rates of
Cho U; Yang SH; Yoo C
J Int Med Res; 2021 Jun; 49(6):3000605211019258. PubMed ID: 34162262
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.
Kobayashi K; Hirata K; Yamaguchi S; Manabe O; Terasaka S; Kobayashi H; Shiga T; Hattori N; Tanaka S; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1071-80. PubMed ID: 25852010
[TBL] [Abstract][Full Text] [Related]
15. 11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.
Yamamoto Y; Nishiyama Y; Kimura N; Kameyama R; Kawai N; Hatakeyama T; Kaji M; Ohkawa M
Mol Imaging Biol; 2008 Sep; 10(5):281-7. PubMed ID: 18543041
[TBL] [Abstract][Full Text] [Related]
16. Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma.
Suchorska B; Giese A; Biczok A; Unterrainer M; Weller M; Drexler M; Bartenstein P; Schüller U; Tonn JC; Albert NL
Neuro Oncol; 2018 Jan; 20(2):279-288. PubMed ID: 29016996
[TBL] [Abstract][Full Text] [Related]
17. Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.
Blanc-Durand P; Van Der Gucht A; Verger A; Langen KJ; Dunet V; Bloch J; Brouland JP; Nicod-Lalonde M; Schaefer N; Prior JO
PLoS One; 2018; 13(6):e0199379. PubMed ID: 29953478
[TBL] [Abstract][Full Text] [Related]
18. Fractal analysis of
Maeda Y; Yamamoto Y; Norikane T; Mitamura K; Hatakeyama T; Miyake K; Nishiyama Y; Kudomi N
EJNMMI Phys; 2021 Nov; 8(1):76. PubMed ID: 34743250
[TBL] [Abstract][Full Text] [Related]
19. Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.
Park JE; Lee JY; Kim HS; Oh JY; Jung SC; Kim SJ; Keupp J; Oh M; Kim JS
Eur Radiol; 2018 Aug; 28(8):3285-3295. PubMed ID: 29488086
[TBL] [Abstract][Full Text] [Related]
20. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]